60 related articles for article (PubMed ID: 4229600)
1. Effects of in vivo hyperoxia on erythrocytes: VII. Inhibition of RBC phosphofructokinase.
Timms R; Mengel CE
Aerosp Med; 1968 Jan; 39(1):71-3. PubMed ID: 4229600
[No Abstract] [Full Text] [Related]
2. Increased red cell osmotic fragility and hematocrit after hyperbaric O2 exposure are related to acidosis.
Braisted JC; Harabin AL
J Lab Clin Med; 1994 Jul; 124(1):105-11. PubMed ID: 8035092
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte fragility and chronic intermittent pigmenturia in a dog.
LeGrange SN; Breitschwerdt EB; Grindem CB; Beutler E
J Am Vet Med Assoc; 1995 Apr; 206(7):1002-6. PubMed ID: 7768705
[TBL] [Abstract][Full Text] [Related]
4. Effect of in vivo hyperoxia on erythrocytes. 8. Effect on adenosine triphosphate (ATP) and related glycolytic enzymes.
Smith D; Timms R; Mengel CE; Jefferson DH
Johns Hopkins Med J; 1968 Mar; 122(3):168-71. PubMed ID: 4230737
[No Abstract] [Full Text] [Related]
5. In vivo hemolysis due to hyperoxia: role of H2 O2 accumulation.
Johnson WP; Jefferson D; Mengel CE
Aerosp Med; 1972 Sep; 43(9):943-5. PubMed ID: 5078815
[No Abstract] [Full Text] [Related]
6. Hematological changes resulting from hyperbaric oxygenation in divers and non-divers.
Bradley ME; Vorosmarti J
Aerosp Med; 1968 May; 39(5):493-7. PubMed ID: 5648739
[No Abstract] [Full Text] [Related]
7. Effects of in vivo hyperoxia on erythrocytes. V. Changes of RBC glycolytic intermediates in mice after in vivo oxygen under high pressure.
O'Malley BW; Mengel CE
Blood; 1967 Feb; 29(2):196-202. PubMed ID: 4381497
[No Abstract] [Full Text] [Related]
8. Age of red blood cells destroyed by in vivo hyperoxia.
Carolla RL; Brubaker LH; Mengel CE
Aerosp Med; 1974 Nov; 45(11):1273-5. PubMed ID: 4429068
[No Abstract] [Full Text] [Related]
9. Activation of membrane skeleton-bound phosphofructokinase in erythrocytes induced by serotonin.
Assouline-Cohen M; Ben-Porat H; Beitner R
Mol Genet Metab; 1998 Mar; 63(3):235-8. PubMed ID: 9608547
[TBL] [Abstract][Full Text] [Related]
10. Effects of in vivo hyperoxia on erythrocytes. VI. Hemolysis occurring after exposure to oxygen under high pressure.
Kann HE; Mengel CE; Clancy WT; Timms R
J Lab Clin Med; 1967 Jul; 70(1):150-7. PubMed ID: 6027093
[No Abstract] [Full Text] [Related]
11. [Effect of activators and inhibitors of SH groups on purified phosphofructokinase activity in hemolysates and intact erythrocytes].
Torliński L; Karoń H; Torlińska T
Acta Haematol Pol; 1984; 15(3-4):125-36. PubMed ID: 6242208
[No Abstract] [Full Text] [Related]
12. [Various properties of phosphofructokinase of rat erythrocytes].
Kühn B; Jacobasch G; Rapoport S
Acta Biol Med Ger; 1969; 23(1):1-17. PubMed ID: 4244705
[No Abstract] [Full Text] [Related]
13. EFFECTS OF IN VIVO HYPEROXIA ON ERYTHROCYTES. 1. HEMOLYSIS IN MICE EXPOSED TO HYPERBARIC OXYGENATION.
MENGEL CE; KANN HE; SMITH WW; HORTON BD
Proc Soc Exp Biol Med; 1964 Jun; 116():259-61. PubMed ID: 14189111
[No Abstract] [Full Text] [Related]
14. Relationship between tocopherol status and in vivo hemolysis caused by hyperoxia.
Goldstein JR; Mengel CE; Carolla RL; Ebbert L
Aerosp Med; 1969 Feb; 40(2):132-5. PubMed ID: 5764489
[No Abstract] [Full Text] [Related]
15. Effect of methemoglobin on in vivo RBC lipid peroxidation.
Osborne CK; Carolla R; Jefferson D; Mengel CE
Aerosp Med; 1973 Jan; 44(1):63-7. PubMed ID: 4689488
[No Abstract] [Full Text] [Related]
16. Effect of cortisol on erythrocyte and reticulocyte enzymes: modulation of phosphofructokinase properties.
Kwiatkowska D; Szajerka G; Kwiatkowska J
Arch Immunol Ther Exp (Warsz); 1983; 31(3):381-7. PubMed ID: 6228205
[TBL] [Abstract][Full Text] [Related]
17. Effects of hyperoxia on red blood cell survival in the normal rat.
Landaw SA; Leon HA; Winchell HS
Aerosp Med; 1970 Jan; 41(1):48-55. PubMed ID: 5443048
[No Abstract] [Full Text] [Related]
18. Red cell osmotic fragility in experimental murine leukemia.
Perk K; Redmon LW; Shachat DA; Moloney JB; Hod I
Isr J Med Sci; 1970; 6(3):358-64. PubMed ID: 5473862
[No Abstract] [Full Text] [Related]
19. Association behaviour of human erythrocyte phosphofructokinase: dependence of molecular weight on enzyme concentration at pH 8.0.
Zimmermann G; Schellenberger W
Acta Biol Med Ger; 1977; 36(3-4):579. PubMed ID: 22973
[No Abstract] [Full Text] [Related]
20. Kinetic properties of mutant enzymes in erythrocyte phosphofructokinase deficiency and erythrocyte pyruvate kinase deficiency.
Shimizu T; Kuwajima M; Kono N; Mineo I; Sumi S; Yonezawa T; Nonaka K; Tarui S
Med J Osaka Univ; 1983 Mar; 33(3-4):49-58. PubMed ID: 6225942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
